Methods of treating sjögren-larssen syndrome
US-2025228840-A1 · Jul 17, 2025 · US
This page is not indexed by search engines while we improve data quality.
Brady Todd patents
Brady Todd is listed as an inventor on 46 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Brady Todd |
| Total patents | 46 |
| First publication | Nov 26, 2015 |
| Latest publication | Jul 17, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Toxic aldehyde related diseases and treatment
US-2025127733-A1 · Apr 24, 2025 · US
Deuterated compounds and uses thereof
US-12240816-B2 · Mar 4, 2025 · US
Toxic aldehyde related diseases and treatment
US-12128013-B2 · Oct 29, 2024 · US
Pharmaceutical formulations and uses thereof
US-12064516-B2 · Aug 20, 2024 · US
Toxic aldehyde related diseases and treatment
US-2024189260-A1 · Jun 13, 2024 · US
Deuterated compounds and uses thereof
US-2024132451-A1 · Apr 25, 2024 · US
Deuterated compounds and uses thereof
US-11845722-B2 · Dec 19, 2023 · US
Toxic aldehyde related diseases and treatment
US-11771664-B2 · Oct 3, 2023 · US
Dry eye disease biomarkers and their use for treatment
US-2023228744-A1 · Jul 20, 2023 · US
Recent patents
Latest publications not already listed above.
Toxic aldehyde related diseases and treatment
US-11701331-B2 · Jul 18, 2023 · US
Deuterated compounds and uses thereof
US-2023174491-A1 · Jun 8, 2023 · US
Quinoline compounds for treating lung, liver, and kidney diseases, disorders, or conditions
US-2023149383-A1 · May 18, 2023 · US
Quinoline compounds for treating respiratory disorders and viral infections
US-2023131929-A1 · Apr 27, 2023 · US
Aldehyde conjugates and uses thereof
US-2022354857-A1 · Nov 10, 2022 · US
Deuterated compounds and uses thereof
US-11459300-B2 · Oct 4, 2022 · US
Treatment of dry eye disease
US-2022211691-A1 · Jul 7, 2022 · US
Toxic aldehyde related diseases and treatment
US-2022202745-A1 · Jun 30, 2022 · US
Combination treatment of ocular inflammatory disorders and diseases
US-2022184057-A1 · Jun 16, 2022 · US
Formulations for treatment of dry eye disease
US-2022133629-A1 · May 5, 2022 · US
Pharmaceutical formulations and uses thereof
US-2021393527-A1 · Dec 23, 2021 · US
Formulations for treatment of dry eye disease
US-11197821-B2 · Dec 14, 2021 · US
Deuterated compounds and uses thereof
US-2021347735-A1 · Nov 11, 2021 · US
Combination treatment of ocular inflammatory disorders and diseases
US-11129823-B2 · Sep 28, 2021 · US
Toxic aldehyde related diseases and treatment
US-2021275469-A1 · Sep 9, 2021 · US
Deuterated compounds and uses thereof
US-11046650-B2 · Jun 29, 2021 · US
Toxic aldehyde related diseases and treatment
US-11007157-B2 · May 18, 2021 · US
Toxic aldehyde related diseases and treatment
US-2020368182-A1 · Nov 26, 2020 · US
Aldehyde conjugates and uses thereof
US-2020246345-A1 · Aug 6, 2020 · US
Deuterated compounds and uses thereof
US-2020199075-A1 · Jun 25, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Aldeyra Therapeutics Inc | 46 |
Top CPC classifications
Most common classification codes across this inventor's patents.